Skip to main content

Meningococcal A Conjugate MenAfriVac

Product overview

Vaccine type
Meningococcal A Conjugate 10 µg
Commercial Name
Meningococcal A Conjugate MenAfriVac
Manofacturer
Serum Institute of India Pvt. Ltd.
Responsible NRA
Central Drugs Standard Control Organization
Country
India

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial + Ampoule
Number of Doses
10
Diluent
Specific Meningococcal diluent
Route of Administration
Intramuscular
Shelf Life
36 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
a. Carton of 50 vials (active)(500 doses) [dimensions 18.5x9.5x6.0]+ carton of 50 ampoules (diluent)[Dimensions 10.5x8.7x17.0]
Tertiary Packaging
Box of 24 cartons of 50 vials (1200 vials/12000 doses) [dimensions 60 x 48 x 41 cm] ; Box of 24 cartons of 50 ampoules (diluent) (1200 ampoules/12000 doses)
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Vaccine Preservative
thiomersal
Vaccine Preservative Concentration
0.01%
Cold Chain Volume
a.2.109 (vial); b. 3.1059 (ampoule) cm3/dose (in secondary packaging)

Attachments

Container Photo
Container Photo (Bigger\ Higher Resolution)
Package Insert